ILA 407.6
(5.43%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5847.00 ILS | -16.74% |
2022 | 7023.00 ILS | 24.1% |
2021 | 5659.00 ILS | -35.46% |
2020 | 8768.00 ILS | 330.23% |
2019 | 2038.00 ILS | 133.72% |
2018 | 872.00 ILS | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 5847.00 ILS | -16.74% |
2023 Q2 | 6252.00 ILS | 0.0% |
2023 Q4 | 5847.00 ILS | 0.0% |
2022 Q2 | 6044.00 ILS | 0.0% |
2022 FY | 7023.00 ILS | 24.1% |
2022 Q4 | 7023.00 ILS | 0.0% |
2021 FY | 5659.00 ILS | -35.46% |
2021 Q2 | 4128.00 ILS | 0.0% |
2021 Q4 | 5659.00 ILS | 0.0% |
2020 Q1 | - ILS | 0.0% |
2020 FY | 8768.00 ILS | 330.23% |
2019 FY | 2038.00 ILS | 133.72% |
2018 FY | 872.00 ILS | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
C-Lab Ltd | 3.62 Billion ILA | 100.0% |